Liverpool Skylilne

Pharmacy and Biomolecular Sciences

Prof Charles Morecroft

Prof Charles Morecroft

Telephone: 0151 231 2296

Publications

Highlighted publications

Morecroft CW, Mackridge AJ, Stokes EC, Gray NJ, Wilson SE, Ashcroft DM, Mensah N, Pickup GB. 2015. Emergency supply of prescription-only medicines to patients by community pharmacists: a mixed methods evaluation incorporating patient, pharmacist and GP perspectives BMJ Open, 5 :e006934-e006934 >DOI

Morecroft CW, Mackridge AJ, Stokes EC, Gray NJ, Wilson SE, Ashcroft DM, Mensah N, Pickup GB. 2015. Involving community pharmacists in pharmacy practice research: experiences of peer interviewing International Journal of Clinical Pharmacy, 37 :31-35 >DOI

Krska J, Morecroft CW, Rowe PH, Poole H. 2014. Measuring the impact of long-term medicines use from the patient perspective INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 36 :675-678 >DOI >Link

Krska J, Morecroft CW, Poole H, Rowe PH. 2013. Issues potentially affecting quality of life arising from long-term medicines use: A qualitative study International Journal of Clinical Pharmacy, 35 :1161-1169 >DOI

Krska J, Morecroft CW, Rowe PH, Poole H. 2013. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study International Journal of Clinical Pharmacy, :1-9 >DOI

Krska J, Morecroft CW. 2013. Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf, 36 :673-680 >DOI >Link

Morecroft CW, Shafiee N, Ford JL, Lisboa PJ, Taylor MJ, Mouzughi Y. 2013. Transformation in the Pharmaceutical Industry – a systematic analysis of operational evidence PDA Journal of Pharmaceutical Science and Technology, 67 :307-322 >DOI

Krska J, Morecroft CW. 2013. Informing patients about medicines--a hospital in-patient survey in England. Patient education and counseling, 90 :276-278

Morecroft CW, Thornton D, Caldwell NA. 2013. Patients’ experiences and expectations of hospital pharmacy services: qualitative study. Health Expectations,

Krska J, Taylor J, Morecroft CW. 2012. Exploring patient experiences of information about adverse drug reactions Pharmacoepidemiology and Drug Safety, 21 :115-115

Morecroft CW, Krska J. 2012. Informing patients about medicines - a hospital in-patient survey in England. Patient Education and Counseling,

Morecroft CW, Krska J. 2012. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions Drug Safety,

Krska J, Morecroft CW. 2010. Views of the general public on the role of pharmacy in public health Journal Pharmaceutical Health Services Research, 1 :33-38

Krska J, Morecroft CW. 2010. Views of the general public on the role of pharmacy in public health J Pharm Health Serv Res, 1 :33-38

John DN, Krska J, Hansford D, Morecroft CW. 2009. How have the pharmacy practice research trust grants supported the development of research capacity? Int J Pharm Pract, 17 :133-134 >Link

Ashcroft DM, Morecroft C, Parker D, Noyce PR. 2006. Likelihood of reporting adverse events in community pharmacy: an experimental study. Qual Saf Health Care, 15 :48-52 >DOI >Link

Ashcroft DM, Morecroft C, Parker D, Noyce PR. 2005. Safety culture assessment in community pharmacy: development, face validity, and feasibility of the Manchester Patient Safety Assessment Framework. Qual Saf Health Care, 14 :417-421 >DOI >Link

Conference publication

Morton M, Parker K, Morecroft C. 2018. Can We Optimise Immunosuppression Strategies in Our Older Renal Transplant Recipients? AMERICAN JOURNAL OF TRANSPLANTATION, American Transplant Congress 18 :804-804 >Link

Lambertsen RT, Tang S, Davies J, Morecroft C. 2016. Serious Gaming for Pharmacy Education Development of A Serious Games for Teaching Pharmacist Communication and Drug Administration in a Virtual Hospital Setting Aljumeily D, Hussain A, Tawfik H, Hamdan H, Dawson T, Hind J. 2016 9TH INTERNATIONAL CONFERENCE ON DEVELOPMENTS IN ESYSTEMS ENGINEERING (DESE 2016), 9th International Conference on Developments in eSystems Engineering (DeSE) :151-156 >DOI >Link

Lee D, Mackridge A, Rodgers R, Morecroft CW, Krska J. 2016. Patients’ need for information and support with medicines after discharge from hospital. Pharmacoepidemiology and Drug Safety, 25 :16-17

lambertsen R, Tang SOT, davies J, morecroft C. 2016. Development of A “PharmaComm” Serious Game for Teaching Pharmacist Communication and Drug Administration in a Virtual Hospital Setting 9th International Conference on Developments in e-Systems Engineering (DESE2016)

Barton G, Henney N, Morecroft C. 2014. A SURVEY OF INTRAVENOUS ANTIBIOTIC ADMINISTRATION PRACTICES IN UK CRITICAL CARE UNITS INTENSIVE CARE MEDICINE, 27th Annual Congress of the European-Society-of-Intensive-Care-Medicine (ESICM) 40 :S261-S261 >Link

Krska J, Morecroft CW, Poole H, Rowe PH. 2013. A novel instrument to measure medicines-related quality of life INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 35 :488-488 >Link

Morecroft CW, Jheeta S, Murray K. 2010. Exploring the physical, psychological and societal impact of chronic childhood conditions. International Social pharmacy conference

Morecroft CW, Mason L. 2010. Information for young people with diabetes – is it empowering? International Journal of Pharmacy Practice, 18 :18-19

Morecroft CW, Oulton P, Krska J, Glenn S. 2009. Young people with asthma and the network of information, advice and support they use to manage their condition. International Journal of Pharmacy Practice 17:(Suppl 1, 17 :A12-A13

Morecroft CW, Caldwell NA, Mottram D, Thornton D. 2009. Patients’ expectations of hospital pharmacy services: quantitative study. International Journal of Pharmacy Practice, 17 :A13-A13

Morecroft CW, Oulton P, Krska J. 2009. Young people with asthma and the network of information, advice and support they use to manage their condition International Journal of Pharmacy Practice, 17 :A12-A13

Krska J, Morecroft C, Poole H, Rowe P, Auckland R. 2009. Developing a medicines-related quality of life measure PHARMACY WORLD & SCIENCE, 31 :501-501 >Link

Morecroft CW, Hughes J, McElroy C, McGarridge H. 2008. Exploring the information needs of parents and carers of children with chronic medical conditions International Journal of Pharmacy Practice, 16 :A33-A33

Morecroft CW, Gill A, Caldwell NA, Wood R, Crolla J , Antwi-Boasiako L. ARE PRESCRIBED DOSES OF MEDICINE FOR CHILDREN MEASURABLE? Archive Child Diseases, NPPG

Morecroft CW, Thornton D, Caldwell NA, Voruganti R, McCann D, Blackwell R, Hutchinson M. Inpatients’ expectations of pharmacy services – qualitative stud Guild of Hospital Pharmacists and United Kingdom Clinical Pharmacy association conference proceedings.

Morecroft CW, Brazil M, Gambhir G, Lee R. The expectations and experiences of Pharmacy for Haematology Patients. 12th BOPA symposium proceedings

Journal article

Mackridge AJ, Rodgers R, Lee D, Morecroft CW, Krska J. 2017. Cross-sectional survey of patients' need for information and support with medicines after discharge from hospital International Journal of Pharmacy Practice, >DOI

Ainscough LP, Roberts M, Ford JL, Morecroft CW, Peak M, Turner MA, Nunn AJ. 2017. Accuracy of Intravenous and Enteral Preparations Involving Small Volumes for Paediatric Use: A Review European Journal of Hospital Pharmacy, >DOI

Wright S, Morecroft CW, Mullen R, Ewing A. 2016. UK hospital patient discharge: the patient perspective European Journal of Hospital Pharmacy,

Shemilt K, Morecroft CW, Ford J, Mackridge A, Green C. 2016. Inpatient prescribing systems across England: a managerial perspective European Journal of Hospital Pharmacy: Science and Practice, >DOI

Bullock S, Morecroft CW, Mullen R, Ewing AB. 2016. Hospital patient discharge process: an evaluation European Journal of Hospital Pharmacy: Science and Practice, 0 >DOI

Morecroft CW, Thornton D, Caldwell NA. 2015. Inpatients' expectations and experiences of hospital pharmacy services: qualitative study. Health Expect, 18 :1009-1017 >DOI >Link

Morecroft CW, Mackridge AJ, Stokes EC, Gray NJ, Wilson SE, Ashcroft DM, Mensah N, Pickup GB. 2015. Emergency supply of prescription-only medicines to patients by community pharmacists: a mixed methods evaluation incorporating patient, pharmacist and GP perspectives BMJ Open, 5 :e006934-e006934 >DOI

Morecroft CW, Mackridge AJ, Stokes EC, Gray NJ, Wilson SE, Ashcroft DM, Mensah N, Pickup GB. 2015. Involving community pharmacists in pharmacy practice research: experiences of peer interviewing International Journal of Clinical Pharmacy, 37 :31-35 >DOI

Krska J, Morecroft CW, Rowe PH, Poole H. 2014. Measuring the impact of long-term medicines use from the patient perspective INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 36 :675-678 >DOI >Link

Morecroft CW, Shafiei N, Ford JL, Lisboa PJ, Taylor MJ. 2013. Transformation in the Pharmaceutical Industry 1 - characterisation of the evolution of the pharmaceutical regulatory environment PDA Journal of Pharmaceutical Science and Technology,

Morecroft CW, Shafiei N, Ford JL, Lisboa P, Taylor MJ, Mouzughi Y. 2013. Transformation in the Pharmaceutical Industry 4 – an expert opinion survey on transformation-induced quality risks PDA Journal of Pharmaceutical Science and Technology,

Morecroft CW, Caldwell NA, Gill A. 2013. Prescribing liquid medication: can the dose be accurately given? Arch Dis Child, 98 :831-832 >DOI >Link

Krska J, Morecroft CW, Poole H, Rowe PH. 2013. Issues potentially affecting quality of life arising from long-term medicines use: A qualitative study International Journal of Clinical Pharmacy, 35 :1161-1169 >DOI

Morecroft CW, Caldwell NA, Gill A. 2013. Prescribing liquid medication: Can the dose be accurately given? Archives of Disease in Childhood, 98 :831-832 >DOI

Krska J, Morecroft CW, Rowe PH, Poole H. 2013. Issues potentially affecting quality of life arising from long-term medicines use: a qualitative study International Journal of Clinical Pharmacy, :1-9 >DOI

Shafiei N, Ford JL, Morecroft CW, Lisboa PJ, Taylor MJ. 2013. Characterization of the evolution of the pharmaceutical regulatory environment. PDA J Pharm Sci Technol, 67 :297-306 >DOI >Link

Shafiei N, Ford JL, Morecroft CW, Lisboa PJ, Taylor MJ, Mouzughi Y. 2013. Transformation in the pharmaceutical industry: transformation-induced quality risks--a survey. PDA J Pharm Sci Technol, 67 :229-246 >DOI >Link

Krska J, Morecroft CW. 2013. Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients. Drug Saf, 36 :673-680 >DOI >Link

Morecroft CW, Shafiei N, Ford JL, Lisboa PJ, Taylor MJ, Mouzughi Y. 2013. Transformation in the Pharmaceutical Industry – a systematic review of the literature PDA Journal of Pharmaceutical Science and Technology, :105-122 >DOI

Morecroft CW, Shafiee N, Ford JL, Lisboa PJ, Taylor MJ, Mouzughi Y. 2013. Transformation in the Pharmaceutical Industry – a systematic analysis of operational evidence PDA Journal of Pharmaceutical Science and Technology, 67 :307-322 >DOI

Krska J, Morecroft CW. 2013. Informing patients about medicines--a hospital in-patient survey in England. Patient education and counseling, 90 :276-278

Morecroft CW, Thornton D, Caldwell NA. 2013. Patients’ experiences and expectations of hospital pharmacy services: qualitative study. Health Expectations,

Morecroft CW, Ford J , Lisboa, P , Taylor, M , Mouzughi, Y . 2012. Transformation in the Pharmaceutical Industry – a systematic review of the literature PDA Journal of Pharmaceutical Science and Technology,

Krska J, Taylor J, Morecroft CW. 2012. Exploring patient experiences of information about adverse drug reactions Pharmacoepidemiology and Drug Safety, 21 :115-115

Morecroft CW, Krska J. 2012. Informing patients about medicines - a hospital in-patient survey in England. Patient Education and Counseling,

Morecroft CW, Krska J. 2012. Patients’ use of information about medicine side effects in relation to experiences of suspected adverse drug reactions Drug Safety,

Morecroft CW. 2011. Engaging in reflection: Error logs and the developing students' skills Pharmacy Education, 11 :172-176

Morecroft CW. 2011. Engaging in reflection Pharmacy Education, 11

Morecroft CW. 2010. Views of the general public on the role of pharmacy in public health Journal Pharmaceutical Health Services Research, 1 :33-38

Krska J, Morecroft CW. 2010. Views of the general public on the role of pharmacy in public health Journal Pharmaceutical Health Services Research, 1 :33-38

Krska J, Morecroft CW. 2010. Views of the general public on the role of pharmacy in public health J Pharm Health Serv Res, 1 :33-38

John DN, Krska J, Hansford D, Morecroft CW. 2009. How have the pharmacy practice research trust grants supported the development of research capacity? Int J Pharm Pract, 17 :133-134 >Link

Morecroft CW, Hughes J, McElroy C, McGarrigle H. 2008. Exploring the information needs of parents and carers of children with chronic medical conditions International Journal of Pharmacy Practice, 16

Morecroft CW, Thornton D, Caldwell NA, Voruganti R, McCann D, Blackwell R, Hutchinson M. 2008. Inpatients' expectations of pharmacy services: qualitative study PHARMACY WORLD & SCIENCE, 30 :1032-1033 >Link

Ryan K, Bissell P, Morecroft C. 2007. Narratives about illness and medication: a neglected theme/new methodology within pharmacy practice research. Part II: medication narratives in practice. Pharm World Sci, 29 :353-360 >DOI >Link

Morecroft CW, Ashcroft D, noyce P. 2006. Repeat dispensing of prescriptions in community pharmacy: a systematic review of the UK literature International Journal of Pharmacy Practice, 14 :11-19

Morecroft C, Cantrill J, Tully MP. 2006. Patients' evaluation of the appropriateness of their hypertension management--a qualitative study. Res Social Adm Pharm, 2 :186-211 >DOI >Link

Bissell P, Ryan K, Morecroft C. 2006. Narratives about illness and medication: a neglected theme/new methodology within pharmacy practice research. Part I: conceptual framework. Pharm World Sci, 28 :54-60 >DOI >Link

Ashcroft DM, Morecroft C, Parker D, Noyce PR. 2006. Likelihood of reporting adverse events in community pharmacy: an experimental study. Qual Saf Health Care, 15 :48-52 >DOI >Link

Morecroft C, Cantrill J, Tully MP. 2006. Individual patient's preferences for hypertension management: a Q-methodological approach. Patient Educ Couns, 61 :354-362 >DOI >Link

Morecroft CW, Ashcroft D, Noyce P, Cantrill JA. 2005. Reporting, reflecting and learning from adverse events in community pharmacy: development and validation of an incident reporting form. Pharmaceutical Journal, 274 :615-617

Morecroft CW, Ashcroft D, Noyce P. 2005. Research Governance and Pharmacy Practice Research: a case study. Pharmaceutical Journal, 274 :650-651

Ashcroft DM, Morecroft C, Parker D, Noyce PR. 2005. Safety culture assessment in community pharmacy: development, face validity, and feasibility of the Manchester Patient Safety Assessment Framework. Qual Saf Health Care, 14 :417-421 >DOI >Link

Morecroft C, Cantrill J, Tully M. 2005. Patients' and general practitioners' views of what constitutes appropriate hypertension management. J Health Serv Res Policy, 10 :91-96 >DOI >Link

Morecroft CW, Cantrill JA, Tully MP. 2004. Can in-depth research interviews have a 'therapeutic' effect for participants? International Journal of Pharmacy Practice 12:247-258, 12 :247-258

Morecroft CW. Views of the general public on the role of pharmacy in public health Journal Public Health Services Research, 1 :33-38

Chapters

Sexton J, Morecroft CW. 2010. Hypertension Dodds LJ. Drugs in use :1-17 Pharmaceutical Pr 9780853697916

Morecroft CW, Sexton J. 2009. Drugs in use Dodds LJ. Drugs in use Pharmaceutical Pr 9780853697916

Report

Morecroft CW, Mackridge A, Stokes E, Gray N. An evaluation of the role of community pharmacists in optimising safe and appropriate medicines use in response to patient requests for emergency supplies: Emergency Supply of Prescription-only Medicines (ESoPoMs). Final report